Jinfeng Shen

Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease

Mark P. Chao, Andrew J. Gentles, Susmita Chatterjee et al. · Cell stem cell · 2017 · 130 citations · Full text

Medicine, Cancer Biology, Hematology +9

Mutant p53 targeting by the low molecular weight compound STIMA‐1

Nicole Zache, Jérémy Lambert, Nina Rökaeus et al. · Molecular Oncology · 2008 · 119 citations · Full text

Medicine, Molecular Biology, Oncology +10

PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73

Nina Rökaeus, Jinfeng Shen, I Eckhardt et al. · Oncogene · 2010 · 59 citations

Life Sciences, Genetics, Molecular Biology +11

PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2

Jinfeng Shen, H Vakifahmetoglu, Hélène Stridh et al. · Oncogene · 2008 · 52 citations

Life Sciences, Cell Biology, Molecular Biology +12

APR-246/PRIMA-1 ^MET rescues epidermal differentiation in skin keratinocytes derived from EEC syndrome patients with <i>p63</i> mutations

Jinfeng Shen, Ellen H. van den Bogaard, Evelyn N. Kouwenhoven et al. · Proceedings of the National Academy of Sciences · 2013 · 44 citations · Full text

Medicine, Dermatology, Molecular Biology +15